drugset / Trial / NCT03604575
A Study to Compare Pharmacokinetics and Pharmacodynamics of Insulin Lispro to Humalog® in Healthy Subjects
RandomizedCrossoverQuadruple-blindBasic science
Summary
Pharmacokinetics and pharmacodynamics study Study of 2 formulation of insulin lispro (Insulin Lispro GEROPHARM vers. Humalog® Eli Lilly)
Timeline
- Start
- 2016-08-22
- Primary completion
- 2016-12-26
- Completion
- 2016-12-26
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Insulin Lispro | Protein / enzyme biologic | 0.3 iu/kg | Subcutaneous |
Indications
No indication recorded.